• Product NameCiprofibrate
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityCiprofibrate is a peroxisome proliferator-activated receptor agonist. It was reported that ciprofibrate decreased the levels of plasma triglycerides and total cholesterol as well as low-density lipoprotein cholesterol. Meanwhile, ciprofibrate elevated plasma levels of high-density lipoprotein cholesterol.
• Target NamePPAR agonist
• CAS No. 52214-84-3
• Calculated MW 289.16
• Formulation C13H14Cl2O3
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular system
  SMILES:CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
  Pathways:Metabolism
  Receptor:PPAR
  Boling pt:424.9C?
  Melting pt:114-118C
  Solubility:Soluble in DMSO
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Domingos H, et al. Arq Bras Cardiol. 2012 Nov;99(5):997-1007.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting